You can watch Inventiva and buy or sell other stocks, options, and ETFs commission-free!
Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France. The listed name for IVA is Inventiva S.A. American Depository Shares.
52 Week High
52 Week Low